About 8 million people suffer from diabetic peripheral neuropathy, which can lead to amputation. Some of Nucynta’s (tapentadol), common side effects are nausea, constipation, vomiting, dizziness, headaches, and drowsiness. Since the drug is a schedule II product, the manufacturer plans to educate healthcare providers and patients about the responsible use and potential misuse of pain medications. What medications are currently used for to treat diabetic peripheral neuropathy?
For more information, please visit Reuters